Strengthening transparency in randomised trials related to multimorbidity: key points and recommendations to guide reporting

Zijun Wang; Jako S. Burgers; Ruitai Shao; Zhaoxiang Bian; Chen Wang; Yaolong Chen; Janne Estill

doi:10.1136/bmjebm-2024-112907

Strengthening transparency in randomised trials related to multimorbidity: key points and recommendations to guide reporting

Zijun Wang, Jako S. Burgers, Ruitai Shao, Zhaoxiang Bian, Chen Wang, Yaolong Chen^*, Janne Estill

^*Corresponding author for this work

The EQUATOR China Centre

Research output: Contribution to journal › Journal article › peer-review

Original language	English
Pages (from-to)	124-126
Number of pages	3
Journal	BMJ Evidence-Based Medicine
Volume	30
Issue number	2
Early online date	5 Jun 2024
DOIs	https://doi.org/10.1136/bmjebm-2024-112907
Publication status	Published - Apr 2025

Access to Document

10.1136/bmjebm-2024-112907

Cite this

@article{87de451be39b4418ba9507b8f50c7001,

title = "Strengthening transparency in randomised trials related to multimorbidity: key points and recommendations to guide reporting",

author = "Zijun Wang and Burgers, {Jako S.} and Ruitai Shao and Zhaoxiang Bian and Chen Wang and Yaolong Chen and Janne Estill",

note = "The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Publisher Copyright: {\textcopyright} Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.",

year = "2025",

month = apr,

doi = "10.1136/bmjebm-2024-112907",

language = "English",

volume = "30",

pages = "124--126",

journal = "BMJ Evidence-Based Medicine",

issn = "2515-446X",

publisher = "BMJ Publishing Group",

number = "2",

}

TY - JOUR

T1 - Strengthening transparency in randomised trials related to multimorbidity

T2 - key points and recommendations to guide reporting

AU - Wang, Zijun

AU - Burgers, Jako S.

AU - Shao, Ruitai

AU - Bian, Zhaoxiang

AU - Wang, Chen

AU - Chen, Yaolong

AU - Estill, Janne

N1 - The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Publisher Copyright: © Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2025/4

Y1 - 2025/4

UR - http://www.scopus.com/inward/record.url?scp=85197618595&partnerID=8YFLogxK

U2 - 10.1136/bmjebm-2024-112907

DO - 10.1136/bmjebm-2024-112907

M3 - Journal article

C2 - 38839262

AN - SCOPUS:85197618595

SN - 2515-446X

VL - 30

SP - 124

EP - 126

JO - BMJ Evidence-Based Medicine

JF - BMJ Evidence-Based Medicine

IS - 2

ER -

Strengthening transparency in randomised trials related to multimorbidity: key points and recommendations to guide reporting

Access to Document

Other files and links

Cite this